The Long Run with Luke Timmerman

Ep188: Art Krieg on Innate Immune System Activators for Cancer

The Long Run with Luke Timmerman ›

1:09:52 | Oct 28th

Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.

Recommendations

Podcast Hosts, Guests or People Mentioned in Episode

🎉 Join the #1 community of podcast lovers and never miss a great podcast.

Sign up